Eva Méndez

Doctor in Biology Science with more than 17 years of research experience, both in the academic and the pharmaceutical sector (Ferrer). She has worked for the last 12 years as chief of different R&D departments in the pharmaceutical industry, coordinating biotechnology, compound management and in-vitro screening. She is a member of the committee of identification, evaluation and selection of new projects and scientific coordinator of multidisciplinary teams with participation in other pharmaceutical and biotech companies as well as public institutions. She is a member of the business adviso… (más)

José Vicente Pons

Currently founder partner at Business Innovation, S.L. A consulting firm specialized in developing biotechnology companies. Previously he was an external advisor, chief executive officer and general director at Natraceutical, S.A., and deputy to the vicepresidency of the Natra Group, General Director at Gonvarri Italia and Manager of the Management Business Consulting Unity for Arthur Andersen. Moreover he is Secretary to the Governing Council of AINIA (Instituto Tecnológico Agroalimentario), Member of the Governing Council of the Asociación española de Biotecnología (ASEBIO), member of th… (más)

José Lora

He is Executive Director of Preclinical Science in Constellation Pharmaceuticals, biotech company located in Boston, MA. He was born in Sevilla and has been in the US for more than 20 years, where he specialized in immunology. At Constellation Pharmaceuticals, José Lora leads the department of immunology, cancer pharmacology, toxicology and DMPK. As part of the team he contributes to defining the strategic and tactical guidelines for epigenetics and drug discovery, and he is responsible of Immunology and Inflammation. Constellation is a leading company in epigenetics drug discovery. He was th… (más)

Manuel Pérez Alonso

Graduated Biology in 1985 and doctor in Molecular Genetics in 1989. Residency at the Molecular Genetics Lab at the University of Lund (Sweden). Chair of Genetics at the University of Valencia, he founded the Development Molecular Genetics Lab from where there were developed three biotechnological patents transferred to the biopharmaceutical industry. He participated in international consortiums of genome sequencing. Scientific advisor to Roche and collaborator at Life Technologies. He published in Nature. He was founding partner, science and strategy director of genomic systems. Founding partn… (más)

Paloma de Miguel

Senior strategy officer in the industry with more than 25 years of ample experience in regulatory matters and medicine development at Baxter and Baxalta. Tested and true trajectory building and leading high performance teams. Ample business and career experience in the main therapeutic areas with deep knowledge of global development pathways. Wide experience in types of products, including medical, biological, vaccines, biosimilars and medical devices. History of global approval of important therapeutic products: Adynovate, Obizur, Rixubis, Advate (Hemofilia), Oncaspar (Oncología), HyQvia, K… (más)